Seroprevalence of COVID-19 in Taiwan revealed by testing anti-SARS-CoV-2 serological antibodies on 14,765 hospital patients
Authors:
Open Access
- 1 October 2020
- journal article
- research article
- Published by Elsevier in The Lancet Regional Health - Western Pacific
- Vol. 3, 100041
Abstract
No abstract availableKeywords
Funding Information
- Taipei Veterans General Hospital
This publication has 15 references indexed in Scilit:
- SARS-CoV-2 Serology: Much Hype, Little DataClinical Chemistry, 2020
- Characteristics of patients with coronavirus disease (COVID‐19) confirmed using an IgM‐IgG antibody testJournal of Medical Virology, 2020
- Assay Techniques and Test Development for COVID-19 DiagnosisACS Central Science, 2020
- Antibody responses to SARS-CoV-2 in patients with COVID-19Nature Medicine, 2020
- Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and ControlFrontiers in Immunology, 2020
- Antibody Detection and Dynamic Characteristics in Patients With Coronavirus Disease 2019Clinical Infectious Diseases, 2020
- Developing antibody tests for SARS-CoV-2The Lancet, 2020
- [Efficient management of novel coronavirus pneumonia by efficient prevention and control in scientific manner].2020
- A Novel Coronavirus from Patients with Pneumonia in China, 2019New England Journal of Medicine, 2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020